Yuan R, Hsu C, Jhuang Y, Liu Y, Hsieh T, Jeng Y
Hepatol Int. 2022; 16(3):562-576.
PMID: 35525880
DOI: 10.1007/s12072-022-10315-w.
Hou W, Xia H, Zhou S, Fan Z, Xu H, Gong Q
Transl Cancer Res. 2022; 8(4):1224-1232.
PMID: 35116864
PMC: 8799119.
DOI: 10.21037/tcr.2019.07.11.
Omata M, Hirotsu Y, Sugiura H, Maejima M, Nagakubo Y, Amemiya K
J Microbiol Immunol Infect. 2021; 54(5):830-838.
PMID: 33593710
PMC: 7784537.
DOI: 10.1016/j.jmii.2020.12.009.
Yang T, Song B, Zhang J, Yang G, Zhang H, Yu W
Gut. 2014; 65(1):124-33.
PMID: 25398772
PMC: 4717356.
DOI: 10.1136/gutjnl-2014-307545.
Hou W, Liu J, Chen P, Wang H, Ye B, Qiang F
Oncol Lett. 2014; 8(3):1249-1254.
PMID: 25120700
PMC: 4114707.
DOI: 10.3892/ol.2014.2253.
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.
Borad M, Champion M, Egan J, Liang W, Fonseca R, Bryce A
PLoS Genet. 2014; 10(2):e1004135.
PMID: 24550739
PMC: 3923676.
DOI: 10.1371/journal.pgen.1004135.
Human hepatocyte carcinogenesis (review).
Shiraha H, Yamamoto K, Namba M
Int J Oncol. 2013; 42(4):1133-8.
PMID: 23426905
PMC: 3622653.
DOI: 10.3892/ijo.2013.1829.
A rare point mutation in the Ras oncogene in hepatocellular carcinoma.
Taketomi A, Shirabe K, Muto J, Yoshiya S, Motomura T, Mano Y
Surg Today. 2012; 43(3):289-92.
PMID: 23266750
DOI: 10.1007/s00595-012-0462-8.
Role of bile salt in regulating Mcl-1 phosphorylation and chemoresistance in hepatocellular carcinoma cells.
Liao M, Zhao J, Wang T, Duan J, Zhang Y, Deng X
Mol Cancer. 2011; 10:44.
PMID: 21507240
PMC: 3107804.
DOI: 10.1186/1476-4598-10-44.
Experimental mouse models for hepatocellular carcinoma research.
Heindryckx F, Colle I, Van Vlierberghe H
Int J Exp Pathol. 2009; 90(4):367-86.
PMID: 19659896
PMC: 2741148.
DOI: 10.1111/j.1365-2613.2009.00656.x.
Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma.
Yoshikawa D, Ojima H, Kokubu A, Ochiya T, Kasai S, Hirohashi S
Br J Cancer. 2009; 100(8):1257-66.
PMID: 19319137
PMC: 2676540.
DOI: 10.1038/sj.bjc.6604988.
Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only.
Mohr L, Banerjee K, Kleinschmidt M, Bartolome Rodriguez M, Wands J
Hepatol Res. 2008; 38(12):1233-40.
PMID: 18631251
PMC: 2582588.
DOI: 10.1111/j.1872-034X.2008.00396.x.
Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran.
Moghaddam S, Haghighi E, Samiee S, Shahid N, Keramati A, Dadgar S
World J Gastroenterol. 2007; 13(4):588-93.
PMID: 17278226
PMC: 4065982.
DOI: 10.3748/wjg.v13.i4.588.
Analysis of N-ras gene mutation and p53 gene expression in human hepatocellular carcinomas.
Luo D, Gove C, Naomov N, Su J, Williams R
World J Gastroenterol. 2002; 4(2):97-99.
PMID: 11819246
PMC: 4688651.
DOI: 10.3748/wjg.v4.i2.97.
Genomic heterogeneity in synchronous hepatocellular carcinomas.
Sirivatanauksorn Y, Sirivatanauksorn V, Bhattacharya S, Davidson B, Dhillon A, Kakkar A
Gut. 1999; 45(5):761-5.
PMID: 10517917
PMC: 1727708.
DOI: 10.1136/gut.45.5.761.
Absence of RAS and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours.
Suchy B, Waldmann V, Klugbauer S, Rabes H
Br J Cancer. 1998; 77(6):952-5.
PMID: 9528840
PMC: 2150103.
DOI: 10.1038/bjc.1998.157.
Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas.
Imai Y, Oda H, Arai M, Shimizu S, Nakatsuru Y, Inoue T
Jpn J Cancer Res. 1996; 87(10):1056-62.
PMID: 8957064
PMC: 5921002.
DOI: 10.1111/j.1349-7006.1996.tb03110.x.
K-ras gene mutation in gall bladder carcinomas and dysplasia.
Ajiki T, Fujimori T, ONOYAMA H, Yamamoto M, Kitazawa S, Maeda S
Gut. 1996; 38(3):426-9.
PMID: 8675098
PMC: 1383074.
DOI: 10.1136/gut.38.3.426.
Concentrating missense mutations in core gene of hepatitis B virus. Evidence for adaptive mutation in chronic hepatitis B virus infection.
Chuang W, Omata M, Ehata T, Yokosuka O, OHTO M
Dig Dis Sci. 1993; 38(4):594-600.
PMID: 8462361
DOI: 10.1007/BF01316786.
Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis.
Ehata T, Omata M, Chuang W, Yokosuka O, Ito Y, Hosoda K
J Clin Invest. 1993; 91(3):1206-13.
PMID: 8450049
PMC: 288078.
DOI: 10.1172/JCI116281.